Marra Alexandre R, Bar Katharine, Bearman Gonzalo M L, Wenzel Richard P, Edmond Michael B
Division of Infectious Diseases, Universidade Federal de São Paulo/Hospital São Paulo, São Paulo, Brazil.
J Am Geriatr Soc. 2006 May;54(5):804-8. doi: 10.1111/j.1532-5415.2006.00698.x.
To determine whether the systemic inflammatory response syndrome (SIRS), clinical course, and outcome of monomicrobial nosocomial bloodstream infection (BSI) due to Pseudomonas aeruginosa or Enterococcus spp. is different in elderly patients than in younger patients.
Historical cohort study.
An 820-bed tertiary care facility.
One hundred twenty-seven adults with P. aeruginosa or enterococcal BSI.
SIRS scores were determined 2 days before the first positive blood culture through 14 days afterwards. Elderly patients (> or =65, n=37) were compared with nonelderly patients (<65, n=90). Variables significant for predicting mortality in univariate analysis were entered into a logistic regression model.
No difference in SIRS was detected between the two groups. No significant difference was noted in the incidence of organ failure, 7-day mortality, or overall mortality between the two groups. Univariate analysis revealed that Acute Physiology And Chronic Health Evaluation (APACHE) II score of 15 or greater at BSI onset; adjusted APACHE II score (points for age excluded) of 15 or greater at BSI onset; and respiratory, cardiovascular, renal, hematological, and hepatic failure were predictors of mortality. Age, sex, use of empirical antimicrobial therapy, and infection with imipenem-resistant P. aeruginosa or vancomycin-resistant enterococci did not predict mortality. Multivariate analysis revealed that hematological failure (odds ratio (OR)=8.1, 95% confidence interval (CI)=2.78-23.47), cardiovascular failure (OR=4.7, 95% CI=1.69-13.10), and adjusted APACHE II > or = 15 at BSI onset (OR=3.1, 95% CI=1.12-8.81) independently predicted death.
Elderly patients did not differ from nonelderly patients with respect to severity of illness before or at the time of BSI. Elderly patients with pseudomonal or enterococcal BSIs did not have a greater mortality than nonelderly patients.
确定铜绿假单胞菌或肠球菌所致的单微生物医院血流感染(BSI)在老年患者与年轻患者中的全身炎症反应综合征(SIRS)、临床病程及转归是否存在差异。
历史性队列研究。
一家拥有820张床位的三级医疗设施。
127例患有铜绿假单胞菌或肠球菌BSI的成人。
在首次血培养阳性前2天至之后14天内测定SIRS评分。将老年患者(≥65岁,n = 37)与非老年患者(<65岁,n = 90)进行比较。将单因素分析中对预测死亡率有显著意义的变量纳入逻辑回归模型。
两组之间未检测到SIRS差异。两组在器官衰竭发生率、7天死亡率或总死亡率方面未发现显著差异。单因素分析显示,BSI发病时急性生理与慢性健康状况评估(APACHE)II评分≥15分;BSI发病时调整后的APACHE II评分(排除年龄因素得分)≥15分;以及呼吸、心血管、肾脏、血液和肝脏衰竭是死亡率的预测因素。年龄、性别、经验性抗菌治疗的使用以及耐亚胺培南铜绿假单胞菌或耐万古霉素肠球菌感染不能预测死亡率。多因素分析显示,血液系统衰竭(比值比(OR)= 8.1,95%置信区间(CI)= 2.78 - 23.47)、心血管系统衰竭(OR = 4.7,95% CI = 1.69 - 13.10)以及BSI发病时调整后的APACHE II≥15分(OR = 3.1,95% CI = 1.12 - 8.81)可独立预测死亡。
老年患者与非老年患者在BSI之前或之时的疾病严重程度方面无差异。患有假单胞菌或肠球菌BSI的老年患者死亡率并不高于非老年患者。